Concepedia

Publication | Open Access

Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology

29

Citations

13

References

2012

Year

Abstract

Chronic low-dose oral etoposide treatment is generally effective and well-tolerated in platinum-resistant ovarian cancer patients.

References

YearCitations

Page 1